These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9596270)

  • 1. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
    Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
    Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
    Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
    Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease.
    Nascimbeni R; Villanacci V; Mariani PP; Di Betta E; Ghirardi M; Donato F; Salerni B
    Am J Surg Pathol; 1999 Oct; 23(10):1256-63. PubMed ID: 10524527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant crypt foci in patients with colorectal cancer.
    Roncucci L; Modica S; Pedroni M; Tamassia MG; Ghidoni M; Losi L; Fante R; Di Gregorio C; Manenti A; Gafa L; Ponz de Leon M
    Br J Cancer; 1998 Jun; 77(12):2343-8. PubMed ID: 9649156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
    Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
    Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
    Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
    Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology of aberrant crypt foci in the human colon.
    Di Gregorio C; Losi L; Fante R; Modica S; Ghidoni M; Pedroni M; Tamassia MG; Gafà L; Ponz de Leon M; Roncucci L
    Histopathology; 1997 Apr; 30(4):328-34. PubMed ID: 9147080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphology of aberrant crypt foci in colorectal carcinoma.
    Norlida AO; Phang KS
    Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
    Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
    J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
    Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
    Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression.
    Thorup I
    Carcinogenesis; 1997 Mar; 18(3):465-72. PubMed ID: 9067543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island methylation in aberrant crypt foci of the colorectum.
    Chan AO; Broaddus RR; Houlihan PS; Issa JP; Hamilton SR; Rashid A
    Am J Pathol; 2002 May; 160(5):1823-30. PubMed ID: 12000733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.
    Tessitore L; Davit A; Sarotto I; Caderni G
    Carcinogenesis; 2000 Aug; 21(8):1619-22. PubMed ID: 10910967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant crypt foci as microscopic precursors of colorectal cancer.
    Cheng L; Lai MD
    World J Gastroenterol; 2003 Dec; 9(12):2642-9. PubMed ID: 14669304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
    Das P; Jain D; Vaiphei K; Wig JD
    Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.